Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Alpine Immune Sciences Inc ALPN

Healthcare Biotechnology
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. The Company's scientific platform uses a directed evolution process to convert native immune system proteins from the immunoglobulin super family (IgSF) into multi-targeted therapeutics... see more

Bullboard (NDAQ:ALPN)

View:
User Avatar Image
(2)
•••
  • streetcredX
Post by streetcredon Oct 25, 2022 7:48pm

Alpine Immune Sciences to drop ALPN - 202 trials after death

https://stcred.com/p/alpine-immune-sciences-to-drop-alpn---202-trials-after-patient-death/6357a52157e63e002e8f3a14
51